Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bioequivalence Studies of Dasatinib 100 Mg Tablets in Healthy Colombian Subjects in Postprandial Condition

NCT05944783 is registered in ClinicalTrials.gov with Centro de Atencion e Investigacion Medica as lead sponsor.

NCT NCT05944783
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05944783 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bioequivalence Studies of Dasatinib 100 Mg Tablets in Healthy Colombian Subjects in Postprandial Condition
Lead sponsor
Centro de Atencion e Investigacion Medica
Phase
Phase 4
Overall status
Not yet recruiting
Start date
September 1, 2025
Completion date
April 30, 2026
Enrollment
46 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myeloma multiple